文献速递精神分裂症与精神病性障碍

突触磷脂作为精神障碍皮层过度兴奋与兴奋/抑制平衡的新靶点

Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders.
PubMed 文献 · Mol Psychiatry · 2018-05-09

该研究在小鼠中显示,星形胶质细胞表达的溶血磷脂酸合成酶自分泌运动因子(ATX)定位于兴奋性突触并调节谷氨酸能传递,其分选与活性受神经元活动动态调控。药物和遗传抑制ATX均可逆转两种精神障碍遗传小鼠模型的类精神分裂症过度兴奋综合征,并在氯胺酮模型中改善电生理与行为表型,且不影响 naive 动物。

要点

  • 星形胶质细胞ATX定位于兴奋性而非抑制性突触,动态调节谷氨酸能传递。
  • 药物与遗传抑制ATX可逆转遗传小鼠模型的类精神分裂症过度兴奋。
  • ATX抑制在氯胺酮模型中 rescue 电生理与行为表型,不影响 naive 动物。

核心结论

  • 星形胶质细胞ATX是谷氨酸能传递的新型调节因子,靶向ATX可能成为治疗精神障碍皮层过度兴奋的新型药物策略。

研究设计与样本

  • 研究采用小鼠模型,包括两种精神障碍遗传模型和一种氯胺酮精神分裂症模型,结合药理学与遗传学ATX抑制。

主要发现

  • ATX在兴奋性突触的星形胶质细胞组分中表达,调节谷氨酸能传递。
  • 星形胶质细胞ATX向细突起分选并转运至兴奋性而非抑制性突触。
  • ATX分选及星形胶质细胞来源ATX的酶活性受神经元活动经星形胶质细胞谷氨酸受体动态调控。
  • 药物和遗传ATX抑制均逆转两种遗传小鼠模型的类精神分裂症过度兴奋综合征。
  • ATX抑制不影响naive动物,但在氯胺酮模型中rescue电生理和行为类精神分裂症表型。

临床怎么用

  • 靶向星形胶质细胞ATX可能作为治疗精神障碍皮层过度兴奋的潜在药物策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lysophosphatidic acid (LPA) is a synaptic phospholipid, which regulates cortical excitation/inhibition (E/I) balance and controls sensory information processing in mice and man. Altered synaptic LPA signaling was shown to be associated with psychiatric disorders. Here, we show that the LPA-synthesizing enzyme autotaxin (ATX) is expressed in the astrocytic compartment of excitatory synapses and modulates glutamatergic transmission. In astrocytes, ATX is sorted toward fine astrocytic processes and transported to excitatory but not inhibitory synapses. This ATX sorting, as well as the enzymatic activity of astrocyte-derived ATX are dynamically regulated by neuronal activity via astrocytic glutamate receptors. Pharmacological and genetic ATX inhibition both rescued schizophrenia-related hyperexcitability syndromes caused by altered bioactive lipid signaling in two genetic mouse models for psychiatric disorders. Interestingly, ATX inhibition did not affect naive animals. However, as our data suggested that pharmacological ATX inhibition is a general method to reverse cortical excitability, we applied ATX inhibition in a ketamine model of schizophrenia and rescued thereby the electrophysiological and behavioral schizophrenia-like phenotype. Our data show that astrocytic ATX is a novel modulator of glutamatergic transmission and that targeting ATX might be a versatile strategy for a novel drug therapy to treat cortical hyperexcitability in psychiatric disorders.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Thalman C, Horta G, Qiao L, et al. Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders. Mol Psychiatry. 2018. PMID: 29743582. doi:10.1038/s41380-018-0053-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。